These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians. Halpern AC; Hanson LJ Int J Dermatol; 2004 Sep; 43(9):638-42. PubMed ID: 15357741 [TBL] [Abstract][Full Text] [Related]
3. Histopathological study of perilesional skin in patients diagnosed with nonmelanoma skin cancer. Apalla Z; Calzavara-Pinton P; Lallas A; Argenziano G; Kyrgidis A; Crotti S; Facchetti F; Monari P; Gualdi G Clin Exp Dermatol; 2016 Jan; 41(1):21-5. PubMed ID: 26189480 [TBL] [Abstract][Full Text] [Related]
4. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers. Zaravinos A; Kanellou P; Spandidos DA Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697 [TBL] [Abstract][Full Text] [Related]
5. Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications. Feldman SR; Fleischer AB Cutis; 2011 Apr; 87(4):201-7. PubMed ID: 21644496 [TBL] [Abstract][Full Text] [Related]
6. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin. Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653 [TBL] [Abstract][Full Text] [Related]
7. Risk of skin cancer development in 672 patients affected by actinic keratosis. Dika E; Fanti PA; Misciali C; Vaccari S; Crisman G; Barisani A; Baraldi C; Ribero S; Patrizi A G Ital Dermatol Venereol; 2016 Dec; 151(6):628-633. PubMed ID: 26381460 [TBL] [Abstract][Full Text] [Related]
8. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience. Tillman DK; Carroll MT Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590 [TBL] [Abstract][Full Text] [Related]
9. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark. Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983 [TBL] [Abstract][Full Text] [Related]
10. Actinic keratosis and squamous cell carcinoma: clinical and pathological features. Filosa A; Filosa G G Ital Dermatol Venereol; 2015 Aug; 150(4):379-84. PubMed ID: 26099352 [TBL] [Abstract][Full Text] [Related]
11. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma. Newman MD; Weinberg JM Cutis; 2007 Apr; 79(4 Suppl):18-28. PubMed ID: 17508492 [TBL] [Abstract][Full Text] [Related]
12. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin. Einspahr J; Alberts DS; Aickin M; Welch K; Bozzo P; Grogan T; Nelson M Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):583-7. PubMed ID: 9264270 [TBL] [Abstract][Full Text] [Related]
13. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin. Sakiz D; Turkmenoglu TT; Kabukcuoglu F Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853 [TBL] [Abstract][Full Text] [Related]
14. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy. Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909 [TBL] [Abstract][Full Text] [Related]
15. ACE and ACE2 expression in normal and malignant skin lesions. Grzegrzolka J; Swiatko K; Pula B; Zamirska A; Olbromski M; Bieniek A; Szepietowski J; Rys J; Dziegiel P; Podhorska-Okolow M Folia Histochem Cytobiol; 2013; 51(3):232-8. PubMed ID: 24203630 [TBL] [Abstract][Full Text] [Related]
16. New and current preventive treatment options in actinic keratosis. Arenberger P; Arenbergerova M J Eur Acad Dermatol Venereol; 2017 Sep; 31 Suppl 5():13-17. PubMed ID: 28805940 [TBL] [Abstract][Full Text] [Related]